This Fall's Children's Oncology Group meeting was energized as the new leadership initiatives to incorporate more and more science into clinical trial design are evolving. Presentations from our lab and program included:
- Targets of opportunity for rhabdomyosarcoma (soft tissue sarcoma session)
- Ad Hoc Preclinical Consortia
to Support Trial Design for DIPG (brain tumor session)
- The Rally Foundation Legacy Gift Pilot Program (pathology session)as well as research on two STS committee agents of interest.
Expect an announcement soon on the initiative from the Rally Foundation, one of the leaders in innovative, grassroots childhood cancer research funding.
